Scott Dreyer, EVP & Chief Commercial Officer at COLLEGIUM PHARMACEUTICAL, INC (COLL), sold 19,336 shares at $36.38 ($704K) on 2024-02-26, disclosed to the SEC on 2024-02-28.
Scheduled sale ($704k) by EVP & Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.38 | 9,336 | $340K | 48.2% |
| 2 | $36.38 | 9,336 | $340K | 48.2% |
| 3 | $37.15 | 664 | $25K | 3.5% |
| Total | $36.41 avg | 19,336 | $704K | 100% |
| Filing → |
| COLL | SELL | 2025-08-20 | $1.3M | — | Filing → |
| COLL | SELL | 2025-08-15 | $370K | — | Filing → |
| COLL | SELL | 2025-03-24 | $1.2M | — | Filing → |